Early response to SPN-812 (viloxazine extended-release) can predict efficacy outcome in pediatric subjects with ADHD: a machine learning post-hoc analysis of four randomized clinical trials.
作者:
主题词
青少年(Adolescent);注意力缺陷障碍伴多动(Attention Deficit Disorder with Hyperactivity);人体质量指数(Body Mass Index);体重(Body Weight);中枢神经系统刺激剂(Central Nervous System Stimulants);儿童(Child);临床试验(主题)(Clinical Trials as Topic);迟效制剂(Delayed-Action Preparations);剂量效应关系, 药物(Dose-Response Relationship, Drug);双盲法(Double-Blind Method);用药计划表(Drug Administration Schedule);女(雌)性(Female);人类(Humans);男(雄)性(Male);随机对照试验(主题)(Randomized Controlled Trials as Topic);治疗结果(Treatment Outcome);维洛沙秦(Viloxazine)
DOI
10.1016/j.psychres.2020.113664
PMID
33418457
发布时间
2021-06-21
- 浏览13
Psychiatry research
113664页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文